UNIVERSITY OF UTAH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1850-02-28

Employees: 10K

Market Cap: -

Website: http://www.utah.edu

Clinical Trials

The Development of a Cognitive Reassurance Training Program

Not Applicable

Terminated

Conditions: Low Back Pain

Interventions: Other: Cognitive reassurance training

First Posted Date: 2017-08-22

Last Posted Date: 2020-04-16

Lead Sponsor: University of Utah

Target Recruit Count: 128

Registration Number: NCT03256617

Locations: 🇺🇸
University of Utah Health Care Out Patient Physical Therapy Clinics, Salt Lake City, Utah, United States

Fixed Versus Weight-Based Enoxaparin Dosing in Thoracic Surgery Patients

Phase 2

Completed

Conditions: Venous Thromboembolism
Deep Venous Thrombosis
Surgery

Interventions: Drug: Fixed Dose Enoxaparin
Drug: Variable Dose Enoxaparin

First Posted Date: 2017-08-16

Last Posted Date: 2020-07-08

Lead Sponsor: University of Utah

Target Recruit Count: 131

Registration Number: NCT03251963

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Hyperhidrosis in Patients With Amputations-Botox

Phase 1

Completed

Conditions: Hyperhidrosis

Interventions: Drug: Botulinum Toxin Type A (Botox)

First Posted Date: 2017-08-01

Last Posted Date: 2022-10-17

Lead Sponsor: University of Utah

Target Recruit Count: 25

Registration Number: NCT03236012

Locations: 🇺🇸
George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah, United States
🇺🇸
University of Utah Hospital, Salt Lake City, Utah, United States

Oxandrolone in Healthy Adults: A Relative Bioavailability Study

Phase 1

Completed

Conditions: Bioavailability

Interventions: Drug: Oxandrin

First Posted Date: 2017-07-14

Last Posted Date: 2018-05-03

Lead Sponsor: University of Utah

Target Recruit Count: 6

Registration Number: NCT03218631

Locations: 🇺🇸
Primary Children's Hospital, Salt Lake City, Utah, United States

Treatment of Chronic Pain With Cannabidiol (CBD) and Delta-9-tetrahydrocannabinol (THC)

Early Phase 1

Recruiting

Conditions: Chronic Pain, Widespread

Interventions: Drug: Placebos
Drug: Cannabidiol
Drug: Delta-9-Tetrahydrocannabinol

First Posted Date: 2017-07-12

Last Posted Date: 2024-04-26

Lead Sponsor: University of Utah

Target Recruit Count: 75

Registration Number: NCT03215940

Locations: 🇺🇸
University Of Utah, Salt Lake City, Utah, United States

Minimization of Bleeding Related Adverse Drug Events in Plastic & Reconstructive Surgery

Phase 2

Completed

Conditions: Venous Thromboembolism
Deep Venous Thrombosis
Pulmonary Embolus
Reconstructive Surgery

Interventions: Drug: Fixed dose
Drug: Variable dose

First Posted Date: 2017-07-11

Last Posted Date: 2020-09-16

Lead Sponsor: University of Utah

Target Recruit Count: 295

Registration Number: NCT03212365

Locations: 🇺🇸
Stanford University, Stanford, California, United States
🇺🇸
University of Utah, Salt Lake City, Utah, United States

Creatine for Treatment of Depression Associated With Type 2 Diabetes

Phase 4

Withdrawn

Conditions: Major Depressive Disorder

Interventions: Drug: Creatine Monohydrate

First Posted Date: 2017-06-28

Last Posted Date: 2024-06-11

Lead Sponsor: University of Utah

Registration Number: NCT03202095

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)

Phase 1

Completed

Conditions: Renal Cell Carcinoma

Interventions: Drug: Avelumab
Drug: Cabozantinib

First Posted Date: 2017-06-27

Last Posted Date: 2024-07-03

Lead Sponsor: University of Utah

Target Recruit Count: 12

Registration Number: NCT03200587

Locations: 🇺🇸
Huntsman Cancer Institute, Salt Lake City, Utah, United States

Collaborative Care for Infants at Risk

Not Applicable

Completed

Conditions: Child Abuse
Child Welfare
Primary Health Care

Interventions: Other: Collaborative Care

First Posted Date: 2017-06-26

Last Posted Date: 2020-11-10

Lead Sponsor: University of Utah

Target Recruit Count: 468

Registration Number: NCT03199326

Locations: 🇺🇸
The Center for Safe and Healthy Families, Primary Children's Hospital Eccles Outpatient Building, 81 North Mario Capecchi Dr 4E-200, Salt Lake City, Utah, United States

Primary Urethral Realignment Versus Suprapubic Cystostomy After Pelvic Fracture Urethral Injury

Completed

Conditions: Urethra Tear
Pelvic Fracture
Surgery
Urethra Injury Male
Trauma

First Posted Date: 2017-06-22

Last Posted Date: 2021-10-27

Lead Sponsor: University of Utah

Target Recruit Count: 200

Registration Number: NCT03195179

Locations: 🇺🇸
University of Utah, Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy